Creative Thinking. Strategic Ideation. Test, Learn, Pivot. These are the critical tenants for Dave and his team as they evolve AZ’s ‘go to market models’ in a way that transcends traditional pharmaceutical marketing and sales approaches. The Portfolio Acceleration Team’s approach is to test practical business hypotheses that result in the quick delivery of innovative commercial capabilities to improve customer and patient experiences. A first of its kind team at AZ, Dave has had early success due to an artful balance of understanding what drives sustainable returns for the business and clarity around stakeholders’ needs and pain points. With a penchant for pushing boundaries and bridging unexpected teams and thought-leaders to challenge the status quo, Dave seeks to find creative solutions to these pain points with a true appreciation for agile learning and scalable development. Prior to joining AstraZeneca in 2010, Dave spent nearly a decade advising life science companies as a management consultant with Accenture.